Ticker
ACONW

Price
0.12
Stock movement up
+0.00 (0.26%)
Company name
Aclarion Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Health Information Services
Market cap
-
Ent value
-1.49M
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-16.82%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2023-01-31

DIVIDENDS

ACONW does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-29.81

FINANCIALS

Per share

Loading...
Per share data
Current share count-
EPS (TTM)-1.20
FCF per share (TTM)-0.63

Income statement

Loading...
Income statement data
Revenue (TTM)49.90K
Gross profit (TTM)-14.33K
Operating income (TTM)-5.84M
Net income (TTM)-9.41M
EPS (TTM)-1.20
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-28.71%
Operating margin (TTM)-11703.93%
Profit margin (TTM)-18863.43%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash2.66M
Net receivables25.50K
Total current assets2.88M
Goodwill0.00
Intangible assets1.22M
Property, plant and equipment0.00
Total assets4.10M
Accounts payable718.28K
Short/Current long term debt0.00
Total current liabilities1.17M
Total liabilities1.17M
Shareholder's equity2.93M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-4.75M
Capital expenditures (TTM)188.34K
Free cash flow (TTM)-4.94M
Dividends paid (TTM)831.05K

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-320.96%
Return on Assets-229.52%
Return on Invested Capital-320.96%
Cash Return on Invested Capital-168.52%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.12
Daily high0.15
Daily low0.12
Daily Volume2K
All-time high0.75
1y analyst estimate-
Beta-
EPS (TTM)-1.20
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ACONWS&P500
Current price drop from All-time high-84.67%-14.91%
Highest price drop-84.71%-56.47%
Date of highest drop30 Jan 20239 Mar 2009
Avg drop from high-59.48%-11.49%
Avg time to new high28 days13 days
Max time to new high116 days1805 days
COMPANY DETAILS
ACONW (Aclarion Inc) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Employees
3
Investor relations
-
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Director of Endoscopic Spine Surgery at the University of Miami Broomfield, CO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW...
January 31, 2023
Broomfield, CO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers ...
January 17, 2023
Broomfield, Colorado--(Newsfile Corp. - January 17, 2023) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers ...
January 17, 2023
Broomfield, CO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers...
December 22, 2022
Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer community through key opinion leader advocacy. Broomfield, CO, Dec. 21, 2022 (GLOB...
December 21, 2022
Dr. Uribe is the fourth national KOL to join the Aclarion team this year. Development of this program supports Aclarion’s commitment to lead with strong clinical evidence and engage the payer communit...
December 19, 2022
Strengthens portfolio by addressing the anaerobic bacteria that can seed into the intervertebral disc, proliferate, and accelerate painful disc degeneration. Successful commercialization of IP holds t...
December 1, 2022
/ Aclarion, Inc. (NASDAQ:ACON)(NASDAQ:ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help phys...
October 25, 2022
Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians ...
October 24, 2022
Presentation on Tuesday, October 25th at 9:00 AM PT Broomfield, Colorado--(Newsfile Corp. - October 12, 2022) - Aclarion, Inc., (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthca...
October 12, 2022
Next page